EP1915151
COMBINATIONS FOR THE TREATMENT OF CANCER COMPRISING ANTI-EGFR ANTIBODY AND VEGFR INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.3.2006EP published:
17.8.2011EP application number:
06739398.3
EPO information:
European Patent Register
Max expiry date:
21.3.2026
Title:
COMBINATIONS FOR THE TREATMENT OF CANCER COMPRISING ANTI-EGFR ANTIBODY AND VEGFR INHIBITORS
Timeline
Today
22.3.2006EP application
17.8.2011EP Publication
Owner
Name:
Amgen, IncAddress:
Patent Operations, M/S 28-2-C One Amgen Center Drive, 91320-1799, Thousand Oaks, California, US
Inventor
Name:
CHANG, DavidAddress:
Calabasas, California, US
Priority
Number:
664381 PDate:
22.3.2005Country:
US
Classification
Categories:
A61K 31/444, A61K 39/395, A61P 35/00